-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Amrize, Lowers Price Target to $65

Benzinga·07/21/2026 17:56:59
语音播报
Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and lowers the price target from $68 to $65.